JP2009501765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009501765A5 JP2009501765A5 JP2008521971A JP2008521971A JP2009501765A5 JP 2009501765 A5 JP2009501765 A5 JP 2009501765A5 JP 2008521971 A JP2008521971 A JP 2008521971A JP 2008521971 A JP2008521971 A JP 2008521971A JP 2009501765 A5 JP2009501765 A5 JP 2009501765A5
- Authority
- JP
- Japan
- Prior art keywords
- lower alkyl
- mono
- phenyl
- amino
- pharmaceutical combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70110405P | 2005-07-20 | 2005-07-20 | |
| PCT/EP2006/064429 WO2007010012A2 (en) | 2005-07-20 | 2006-07-19 | Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009501765A JP2009501765A (ja) | 2009-01-22 |
| JP2009501765A5 true JP2009501765A5 (https=) | 2009-05-28 |
Family
ID=37517254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008521971A Pending JP2009501765A (ja) | 2005-07-20 | 2006-07-19 | ピリミジルアミノベンズアミドとｍＴＯＲキナーゼ阻害剤の組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080200486A1 (https=) |
| EP (2) | EP2253320A1 (https=) |
| JP (1) | JP2009501765A (https=) |
| KR (3) | KR20120079163A (https=) |
| CN (1) | CN101222925A (https=) |
| AU (1) | AU2006271650B8 (https=) |
| BR (1) | BRPI0613692A2 (https=) |
| CA (1) | CA2615254C (https=) |
| MX (1) | MX2008000897A (https=) |
| RU (1) | RU2443418C2 (https=) |
| WO (1) | WO2007010012A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011004585A (es) * | 2008-10-31 | 2011-06-01 | Novartis Ag | Combinacion de un inhibidor de fosfatidilinositol-3-cinasa (p13k) y un inhibidor de mtor. |
| KR102432999B1 (ko) | 2018-08-29 | 2022-08-17 | 고려대학교 산학협력단 | 마이크로파 조사를 이용한 체외 아밀로이드 응집체 합성방법 |
| CN110613848A (zh) * | 2019-10-29 | 2019-12-27 | 西安交通大学医学院第二附属医院 | Tipe1作为靶点在制备防治银屑病的药物中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT98990A (pt) | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
| US5120842A (en) | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
| US5100883A (en) | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
| US5118678A (en) | 1991-04-17 | 1992-06-02 | American Home Products Corporation | Carbamates of rapamycin |
| US5118677A (en) | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
| US5151413A (en) | 1991-11-06 | 1992-09-29 | American Home Products Corporation | Rapamycin acetals as immunosuppressant and antifungal agents |
| GB9125660D0 (en) | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compound |
| ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| ZA935111B (en) | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
| US5256790A (en) | 1992-08-13 | 1993-10-26 | American Home Products Corporation | 27-hydroxyrapamycin and derivatives thereof |
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| US5258389A (en) | 1992-11-09 | 1993-11-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives |
| WO1995014023A1 (en) | 1993-11-19 | 1995-05-26 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| US5912253A (en) | 1993-12-17 | 1999-06-15 | Novartis Ag | Rapamycin derivatives |
| EP0833828B1 (en) | 1995-06-09 | 2002-11-20 | Novartis AG | Rapamycin derivatives |
| PL409579A1 (pl) * | 2001-02-19 | 2015-03-02 | Novartis Ag | Leczenie raka |
| AU2003248813A1 (en) * | 2002-07-05 | 2004-01-23 | Beth Israel Deaconess Medical Center | Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
| GB0215676D0 (en) * | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
-
2006
- 2006-07-19 WO PCT/EP2006/064429 patent/WO2007010012A2/en not_active Ceased
- 2006-07-19 CA CA2615254A patent/CA2615254C/en not_active Expired - Fee Related
- 2006-07-19 US US11/995,870 patent/US20080200486A1/en not_active Abandoned
- 2006-07-19 BR BRPI0613692-3A patent/BRPI0613692A2/pt not_active IP Right Cessation
- 2006-07-19 EP EP10175106A patent/EP2253320A1/en not_active Withdrawn
- 2006-07-19 AU AU2006271650A patent/AU2006271650B8/en not_active Ceased
- 2006-07-19 KR KR1020127013855A patent/KR20120079163A/ko not_active Ceased
- 2006-07-19 RU RU2008105828/15A patent/RU2443418C2/ru not_active IP Right Cessation
- 2006-07-19 KR KR1020137018172A patent/KR20130087058A/ko not_active Ceased
- 2006-07-19 CN CNA2006800263848A patent/CN101222925A/zh active Pending
- 2006-07-19 MX MX2008000897A patent/MX2008000897A/es active IP Right Grant
- 2006-07-19 KR KR1020087003911A patent/KR20080041206A/ko not_active Ceased
- 2006-07-19 JP JP2008521971A patent/JP2009501765A/ja active Pending
- 2006-07-19 EP EP06764229A patent/EP1909794A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015207757B2 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | |
| BR112019011410A2 (pt) | métodos para tratar um paciente tendo câncer, para aumentar uma população da célula efetora imune pró-inflamatória, para aumentar o nível de ativação de célula t, para reduzir a população de células t reguladoras, para inibir a função imunossupressora das células t reguladoras, para o realce de longa duração da geração das células t de memória específicas de tumor e para proteger as células imunológicas intratumorais da quimioterapia. | |
| JP2011530607A5 (https=) | ||
| JP2019518033A (ja) | Ｓｈｐ２の活性を阻害するための化合物および組成物 | |
| JP2017528487A5 (https=) | ||
| EP3274344B1 (en) | Formylated n-heterocyclic derivatives as fgfr4 inhibitors | |
| CN103491955B (zh) | 磷脂酰肌醇-3-激酶(pi3k)抑制剂及mtor抑制剂的组合 | |
| JP2015500884A5 (https=) | ||
| TWI824010B (zh) | 治療血癌之組合療法 | |
| EP3268490A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | |
| KR20180013850A (ko) | 치환된 2,3-디히드로이미다조[1,2-c]퀴나졸린의 용도 | |
| JP2012526772A5 (https=) | ||
| JP2009543874A5 (https=) | ||
| RU2011105059A (ru) | Применение производных пиримидиламинобензамида для лечения фиброза | |
| JP2009537606A5 (https=) | ||
| JP2013525292A (ja) | 有機化合物の組合せ | |
| JP2009501765A5 (https=) | ||
| RU2008127264A (ru) | Производные пиримидиламинобензамида, предназначенные для лечения нейрофиброматоза | |
| WO2018215282A1 (en) | Combination of bub1 and pi3k inhibitors | |
| JP2014525929A5 (https=) | ||
| JP2012519668A5 (https=) | ||
| RU2443418C2 (ru) | КОМБИНАЦИЯ ПИРИМИДИЛАМИНОБЕНЗАМИДА И ИНГИБИТОРА КИНАЗ mTOR | |
| DK3124025T3 (en) | COMBINATION BETWEEN 3 - [(3 - {[4- (4-MORPHOLINYLMETHYL) -1H-PYRROL-2-YL] -METHYLENE} -2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL) -METHYL ] -1,3-THIAZOLIDIN-2,4-DION AND AN EGFR-TYROKINASE INHIBITOR | |
| JP2023063270A5 (https=) | ||
| EP4441052A1 (en) | Compounds |